share_log

HC Wainwright & Co. Maintains Neutral on Macrogenics, Lowers Price Target to $4

Benzinga ·  May 14 00:25

HC Wainwright & Co. analyst Robert Burns maintains Macrogenics (NASDAQ:MGNX) with a Neutral and lowers the price target from $16 to $4.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment